Infectious Disease General
RSSArticles
-
New Once-a-Day Pill Submitted to FDA
HIV antiretroviral therapy treatment soon will become a whole lot simpler than most antibiotic regimens when the FDA approves the combination pill of efavirenz/emtricitabine/ tenofovir (Truvada/Sustiva). -
Treatment of Cholera in Adults with Single-Dose Azithromycin
This article originally appeared in the August 2006 issue of Travel Medicine Advisor. It was edited by Frank Bia, MD, MPH, and peer reviewed by Philip R. Fischer, MD, DTM&H. Dr. Fishcer is Professor of Pediatrics, Divsion of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN. Dr. Fishcer reports no financial relationships relevant to this field of study. -
Multidrug-Resistant Tuberculosis (MDR-TB)
The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance began collecting its data in 1994 on drug resistance in 90 countries. -
Updates: Mosquitoes and Patients with HIV; Pneumococcal Vaccination in SLE and RA; Highly Resistant GC Marches Toward U.S.
-
Parvovirus B19 Transmissions During Thoracic Surgery from a Pooled Plasma Product
-
Updates: Antiretroviral Therapy and Pregnancy; Cryptococcosis on Vancouver Island; Foodborne Outbreaks
-
Pharmacology Watch: HRT - Position Paper Places Benefits in Question
-
Clinical Briefs in Primary Care Supplement
-
Updates: Long-Term Care Facilities and VRE; Gay Men and Occult GC
-
Panel: Early treatment of HCV not clear-cut